The "Give Kids a Chance Act of 2025" is designed to enhance the development and investigation of drugs specifically for pediatric cancers, ensuring that children have access to effective therapies tailored to their unique medical needs. The legislation introduces new requirements for drug manufacturers to conduct studies on pediatric drugs, particularly those targeting specific molecular pathways in pediatric cancers.